ArticleClinical and experimental nephrology2025
Evaluation of albumin-based proteinuria selectivity index as a substitute for transferrin-based proteinuria selectivity index.
Article in Clinical and experimental nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe proteinuria selectivity index (SI) is a valuable marker of glomerular permeability. Traditionally, SI has been calculated using the clearance ratio of immunoglobulin G (IgG) to transferrin-SI (Tf)-due to historical limitations in albumin measurement accuracy. However, recent advances have enabled precise quantification of albumin, raising the possibility of using an albumin-based SI-SI (Alb)-in clinical practice. This study aimed to evaluate the correlation between SI (Alb) and SI (Tf) and to compare their diagnostic utility in patients with proteinuria.
methodsWe retrospectively analyzed 265 patients with proteinuria > 0.15 g/g·Cr who visited Ehime University Hospital between January 2014 and April 2024. SI (Alb) and SI (Tf) were calculated as the clearance ratios of IgG to albumin and IgG to transferrin, respectively. Linear regression was used to assess their correlation. Diagnostic performance for minimal change disease (MCD) in patients with nephrotic-range proteinuria (≥ 3.5 g/g·Cr) was evaluated using ROC curves, and AUCs were compared using DeLong's test.
resultsSI (Alb) strongly correlated with SI (Tf) in patients with proteinuria ≥ 3.5 and < 3.5 g/g·Cr. Among patients with nephrotic-range proteinuria, both indices effectively identified MCD, yielding comparable areas under the ROC curve. Sensitivity and specificity at optimal thresholds were similarly high.
conclusionSI (Alb) shows a high degree of concordance with SI (Tf) and offers comparable diagnostic accuracy for identifying MCD. Given its practical advantages, SI (Alb) may serve as a reliable and convenient alternative to SI (Tf) for assessing glomerular selectivity in patients with proteinuria.
Indexed as
Identifiers
40856909What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.